Coarctation of the aorta in an infant exposed to etanercept in utero

Journal of Rheumatology

Volumn 36, Issue 12, 2009, Pages 2848-

  Hemmati, Iman ^a   Ensworth, Stephanie ^a   Shojania, Kam ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AORTA COARCTATION; CASE REPORT; CESAREAN SECTION; CONGENITAL HEART MALFORMATION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG CLASSIFICATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG HALF LIFE; DRUG INTERMITTENT THERAPY; FEMALE; FETUS; FETUS MONITORING; GESTATIONAL AGE; HEART DEVELOPMENT; HUMAN; INFANT; LETTER; PREGNANCY; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; PUERPERIUM; RHEUMATOID ARTHRITIS; SYNDROME VATER; TERATOGENESIS; TREATMENT OUTCOME;

ADULT; ANIMALS; ANTIRHEUMATIC AGENTS; AORTA; AORTIC COARCTATION; ARTHRITIS, RHEUMATOID; FATAL OUTCOME; FEMALE; FETUS; HUMANS; IMMUNOGLOBULIN G; INFANT; MALE; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 72449150761     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090430     Document Type: Letter

References (9)

1. Child JS, Friedman WF. Congenital heart disease in the adult. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al, editors. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill; 2005:1381-1390
2. Lockshin MD. Treating rheumatic diseases in pregnancy: dos and don'ts. Ann Rheum Dis 2006;65 Suppl 3:58-60.
3. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 2003;30:241-246 (Pubitemid 36152584)
4. Berthelot JM, De Bandt M, Goupille P, Solau-Gervais E, Lioté F, Goeb V, et al, on behalf of CRI (Club Rhumatismes et Inflammation). Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature. Joint Bone Spine 2009;76:28-34.
5. Sills ES, Perloe M, Tucker MJ, Kaplan CR, Palermo GD. Successful ovulation induction, conception, and normal delivery after chronic therapy with etanercept: a recombinant fusion anticytokine treatment for rheumatoid arthritis. Am J Reprod Immunol 2001;46:366-368 (Pubitemid 33034820)
6. Sinha A, Patient C. Rheumatoid arthritis in pregnancy: successful outcome with anti-TNF agent (Etanercept). J Obstet Gynaecol 2006;26:689-691 (Pubitemid 44663890)
7. Feyertag J, Dinhof G, Salzer H, Dunky A. Pregnancy in a rheumatoid arthritis patient treated with etanercept. Ann Rheum Dis 2004;63 Suppl 1:198.
8. Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. J Rheumatol 2006;33:1014-1017
9. Moore KL, Persaud TVN. The cardiovascular system. In: Moore KL, Persaud TVN. The developing human. 8th ed. Philadelphia: Saunders; 2008:285-308.